Severe coronavirus disease 2019 (COVID-19) is associated with immunothrombotic, neutrophil-containing vessel occlusions in the lung.
For patients with high-risk CVD, high-dose trivalent inactivated influenza vaccination does not reduce cardiopulmonary hospitalization or all-cause mortality.
Study authors evaluated the performance of symptom-based definitions to detect influenza in a cohort of pregnant women in India, Peru, and Thailand.
Older adults are less likely to get a COVID-19 vaccine than a flu vaccine, according to the University of Michigan National Poll on Healthy Aging.
Several previously FDA-approved medicines were approved for additional uses in November 2020.
Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.
The 2018 to 2019 influenza vaccine effectiveness was about 40% to 60% for reducing pediatric influenza A-associated hospitalizations.
Researchers conducted a retrospective cohort study to compare characteristics of children with a confirmed diagnosis of COVID-19, seasonal influenza A, and influenza B.
One-third of parents say they will forgo the flu vaccination for their children this year, despite public health recommendations.
Influenza vaccinations were found to be underutilized among groups who are considered to be at high risk for complications from infection.
When states lifted their stay-at-home orders, reopened businesses, and relaxed social distancing rules, the number of cases of COVID-19 exploded—what will happen when the flu season begins?
Influenza vaccination should occur by the end of October, if possible.
The Theraflu Home FluTest, a novel rapid influenza diagnostic test, demonstrated good sensitivity and specificity for both influenza A and B viruses.
Excess mortality during the peak of the 1918 H1N1 influenza pandemic was comparable to that seen early in the COVID-19 pandemic outbreak in New York City.
Following the initial pandemic wave of SARS-CoV-2 infections, it is unclear what trajectory of transition SARS-CoV-2 might take.
The Advisory Committee on Immunization Practices encourages all Americans to receive the flu vaccine between September and October.
The analysis included 241,551 patients monitored for a median of 4 years.
A team of investigators report on the findings from a randomized controlled trial of 3 enhanced influenza vaccines and a standard-dose vaccine in older adults.
In response to the COVID-19 pandemic, New York State implemented a series of community mitigation strategies, and monitoring approaches are needed to assess the effect of these interventions.
Targeting the elderly (individuals aged 65 years) for influenza vaccination may not decrease hospitalization or mortality rates in this population.